Daniel Moorhead Acquires 4,340 Shares of Beyond Air (NASDAQ:XAIR) Stock

Beyond Air, Inc. (NASDAQ:XAIRGet Free Report) CFO Daniel Moorhead purchased 4,340 shares of the business’s stock in a transaction that occurred on Wednesday, July 29th. The shares were bought at an average price of $5.76 per share, for a total transaction of $24,998.40. Following the completion of the purchase, the chief financial officer directly owned 4,340 shares in the company, valued at $24,998.40. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Beyond Air Stock Performance

NASDAQ XAIR opened at $5.28 on Friday. The company has a debt-to-equity ratio of 3.48, a current ratio of 3.80 and a quick ratio of 3.59. Beyond Air, Inc. has a 1 year low of $5.02 and a 1 year high of $95.60. The company has a market capitalization of $3.80 million, a PE ratio of -0.06 and a beta of 0.22. The company has a fifty day moving average of $7.69 and a two-hundred day moving average of $14.21.

Beyond Air (NASDAQ:XAIRGet Free Report) last issued its quarterly earnings data on Friday, June 26th. The company reported ($15.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($11.33) by ($4.07). Beyond Air had a negative return on equity of 350.00% and a negative net margin of 432.99%.The firm had revenue of $1.91 million for the quarter, compared to analysts’ expectations of $2.30 million.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Beyond Air in a research report on Tuesday, July 21st. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $200.00.

Check Out Our Latest Stock Report on Beyond Air

Hedge Funds Weigh In On Beyond Air

Several institutional investors have recently bought and sold shares of XAIR. Virtu Financial LLC acquired a new stake in shares of Beyond Air in the 3rd quarter worth $48,000. Geode Capital Management LLC boosted its holdings in shares of Beyond Air by 57.5% in the fourth quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after acquiring an additional 24,695 shares in the last quarter. Osaic Holdings Inc. increased its stake in shares of Beyond Air by 26.4% during the second quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after acquiring an additional 34,000 shares during the period. Finally, Alyeska Investment Group L.P. acquired a new position in shares of Beyond Air during the third quarter worth about $1,753,000. 31.50% of the stock is owned by institutional investors and hedge funds.

Beyond Air Company Profile

(Get Free Report)

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.

Recommended Stories

Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.